HYDERABAD, India & PRINCETON, N.J.--(BUSINESS WIRE)--Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY along with its subsidiaries together referred to as “Dr.

The recall involves Lot# GMML24026A (NDC# 29300-415-19) with an expiration date of September 2027. Unichem Pharmaceuticals is recalling 1 lot of Cyclobenzaprine Hydrochloride Tablets USP, 10mg due to ...

A medication used to treat attention deficit/hyperactivity disorder (ADHD) and narcolepsy carries the FDA’s most serious warning, but got recalled for another reason: metal was found embedded in a ...

08/27/2025– East Brunswick, NJ, Unichem Pharmaceuticals (USA), Inc. is voluntarily recalling one (1) lot of Cyclobenzaprine Hydrochloride Tablets USP 10 mg, to the consumer level. The Cyclobenzaprine ...

Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration (FDA) for verapamil hydrochloride extended-release tablets USP, 120 mg, 180 mg and 240 mg ...

A pharmaceutical company is recalling one of its products after discovering that the pill bottle could be filled with the wrong medication. According to the Food and Drug Administration (FDA), Unichem ...

Alembic Pharmaceuticals said on November 15 that it has secured final approval from the US Food and Drug Administration. The approval is granted for one of its important generic filings. The approval ...

HYDERABAD, India & PRINCETON, N.J.--(BUSINESS WIRE)--Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today ...